Karriereverlauf von Pierre V. Verroye
Ehemalige bekannte Positionen von Pierre V. Verroye
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Boehringer Mannheim Corp. (California) | Corporate Officer/Principal | 01.01.1998 | 01.01.1998 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | 11.06.2012 | - |
Ausbildung von Pierre V. Verroye
| Université Catholique de Lille | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
| Boehringer Mannheim Corp. (California) |
- Börse
- Insiders
- Pierre V. Verroye
- Erfahrung
